Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70060 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Vijay H Masand and 8 co-authors. Institution: Department of Chemistry, Vidya Bharati Mahavidyalaya, Amravati, Maharashtra, India. Major MEDLINE topics: Oxygen, Drug Discovery, United States Food and Drug Administration, Drug Approval. Cited 7 times so far (Crossref); 68 references. Funded by: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Abstract (original language)
Despite advancements in molecular design rules and understanding biochemical processes, the field of drug design and discovery seeks to minimize the number and duration of synthesis‐testing cycles to convert lead compounds into drug candidates. A promising strategy involves gaining insightful understanding of key heteroatoms such as oxygen and nitrogen. This work presents a comprehensive analysis of oxygen atoms in approved drugs, aiming to streamline drug design and discovery efforts. The study examines the frequency, distribution, prevalence, and diversity of oxygen atoms in a dataset of 2049 small molecules approved by the FDA and other agencies. The analysis focuses on various types of oxygen atoms, including sp 3 , sp 2 ‐hybridized, ring, and nonring. In general, existence of sp 3 ‐O slightly outperforms sp 2 ‐O, which is associated with balancing various factors such as flexibility, solubility, stability, and pharmacokinetics, in addition to activity and selectivity. In approved drugs, majority of oxygen atoms are present within 4 Å from the COM of the molecule. This analysis offers valuable understanding of oxygen distribution, which could be used during the multiparameter optimization process, facilitating the transformation of a hit/lead compound into a potential drug candidate.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, Vidya Bharati Mahavidyalaya, Amravati, Maharashtra, India.
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Sub-Campus, Dharashiv, Maharashtra, India.
- Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region, Iraq.
- Department of Agroecology and Environmental Protection, Faculty of Agrobiotechnical Sciences Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
- Department of Medicinal Chemistry, Dr. Rajendra Gode Institute of Pharmacy, Amravati, Maharashtra, India.
ORCID profiles: Vijay H Masand, Meghshyam K Patil
Funding
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia
Cite
APA
Masand, V. H., Patil, M. K., Al-Hussain, S. A., Samad, A., Rastija, V., Jawarkar, R. D., Masand, G. S., Gawali, R. G., & Zaki, M. E. A. (2025). Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70060
Vancouver
Masand VH, Patil MK, Al-Hussain SA, Samad A, Rastija V, Jawarkar RD, et al. Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70060
BibTeX
@article{Masand2025,
author = {Masand, Vijay H and Patil, Meghshyam K and Al-Hussain, Sami A and Samad, Abdul and Rastija, Vesna and Jawarkar, Rahul D and Masand, Gaurav S and Gawali, Rakhi G and Zaki, Magdi E A},
title = {Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70060}
}
EUVIMED